Article
Unraveling MCL biology to understand resistance and identify vulnerabilities
29 Mar 2024
Abstract excerpt
ABSTRACT: Mantle cell lymphoma (MCL) is a rare (5%-7%), aggressive B-cell non-Hodgkin lymphoma with well-defined hallmarks (eg, cyclin D1, SOX11), and its expansion is highly dependent on the tumor microenvironment (TME). Parallel drastic progress in the understanding of lymphomagenesis and improved treatments led to a paradigm shift in this B-cell malignancy with now prolonged disease-free survival after...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
